MedPath

Scanadu Urine Device Validation Study Protocol

Not Applicable
Conditions
Urinary Tract Infections
Ketone Urine
Hematuria
Proteinuria
Glucose Intolerance
Interventions
Device: Scanadu Urine Device
Registration Number
NCT02973178
Lead Sponsor
Scanadu, Inc.
Brief Summary

This study will test Scanadu Urine Device for clinical performance and usability.

Detailed Description

The objectives of this study are to:

* Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396).

* Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.

* Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Female and male
  • 18 years old or older
  • Pregnant or not pregnant
  • Must have experience using an Apple iPhone
  • Have no visual impairments
  • Able to hold Smart Phone horizontally in raised dominant hand
  • Must be able to read and understand English
  • Must provide Informed Consent
Exclusion Criteria
  • Has a known history of a visual impairment that may affect reading and navigating the Scanadu Urine app
  • Unable to void and collect urine specimen for testing
  • Unable to hold phone steady (horizontally) or has history of tremors or conditions such as Parkinson's disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
UsabilityScanadu Urine DeviceEvaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.
ReproducibilityScanadu Urine DeviceEvaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels.
Method ComparisonScanadu Urine DeviceEvaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: * The visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396), * Scanadu Urine Device tests performed by lab technicians.
Primary Outcome Measures
NameTimeMethod
Usability: % successful scans in three tests conducted by lay users in following the app on the iPhone and obtain user experience on questionnaireSingle visit in one day

Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.

Method Comparison: Conduct two tests by following iPhone app (self and patient samples), results in concordance with professional testers; achieve accuracy in different concentrations of six urine analytes each using approximately 20 samples per level.Single visit in one day

Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396).

Reproducibility: Lay user's ability to repeat a urine test nine times by following iPhone app and obtain nine results that are in concordance.Single visit in one day

Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

West Coast Research, LLC

🇺🇸

San Leandro, California, United States

© Copyright 2025. All Rights Reserved by MedPath